The iHIVARNA project
(full title: Therapeutic TriMIx / mRNA based Vaccine in Chronic HIV-1 Infected Patients on Antiretroviral Therapy) is funded with approximately 6 million Euro granted by the European Commission in the 7th Framework Programme, coordinated by Dr. Felipe García of IDIBAPS (Institut d’Investigacions Biomèdiques August Pi i Sunyer) and carried out by 8 leading research
institutions and SMEs.
- Consorci Institut d’Investigacions Biomèdiques August Pi
i Sunyer (IDIBAPS) - Instituut voor Tropische Geneeskunde (ITM)
- Vrije Universiteit Brussel (VUB)
- eTheRNA BVBA (eTheRNA)
- Erasmus Universitair Medisch Centrum Rotterdam (EMC)
- Institut de Recerca de la Sida – Caixa (IRSICAIXA)
- Synapse Research Management Partners S.L. (SYNAPSE)
- Asphalion (ASPHALION)
For more information:
Ms. Mireia Manent
Project Manager, SYNAPSE
[email protected]
T +34 933 006 061
Ms. Montse Pérez
Marketing Department, ASPHALION
[email protected]
T +34 93 238 59 45
iHIVARNA: The research leading to this results has received funding from the European Comunity’s Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 602570.
